Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Non-Current Deffered Revenue (2016 - 2019)

Historic Non-Current Deffered Revenue for Healthequity (HQY) over the last 6 years, with Q1 2019 value amounting to $3.0 million.

  • Healthequity's Non-Current Deffered Revenue rose 2392.48% to $3.0 million in Q1 2019 from the same period last year, while for Jan 2019 it was $3.0 million, marking a year-over-year increase of 2392.48%. This contributed to the annual value of $3.0 million for FY2019, which is 2392.48% up from last year.
  • Per Healthequity's latest filing, its Non-Current Deffered Revenue stood at $3.0 million for Q1 2019, which was up 2392.48% from $2.5 million recorded in Q2 2018.
  • Healthequity's 5-year Non-Current Deffered Revenue high stood at $3.0 million for Q1 2019, and its period low was $145000.0 during Q3 2015.
  • Its 5-year average for Non-Current Deffered Revenue is $1.3 million, with a median of $1.3 million in 2016.
  • Its Non-Current Deffered Revenue has fluctuated over the past 5 years, first plummeted by 6666.67% in 2015, then soared by 64206.9% in 2016.
  • Healthequity's Non-Current Deffered Revenue (Quarter) stood at $195000.0 in 2015, then soared by 564.1% to $1.3 million in 2016, then surged by 71.89% to $2.2 million in 2017, then rose by 10.78% to $2.5 million in 2018, then grew by 20.36% to $3.0 million in 2019.
  • Its Non-Current Deffered Revenue was $3.0 million in Q1 2019, compared to $2.5 million in Q2 2018 and $2.4 million in Q1 2018.